Opinion: Honorary Authorship Is Antiquated Etiquette

Though the practice may be well-intentioned, naming courtesy authors can hurt science and scientists.

Written byMidhat H. Abdulreda
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

FLICKR, VIDALIA_11Despite more than a century of academic research and scientific publication, authorship policies and guidelines have only been codified in the last three decades. While this may have been a recent arrival to research standards, authorship guidelines are increasingly being adopted by scientists, funding bodies, and publishers alike. The National Institutes of Health (NIH) and the National Science Foundation (NSF) have established authorship guidelines as part of their mandates for the responsible conduct of research. Academic institutions, too, have either already adopted or are in the process of establishing authorship guidelines and policies in accordance with requirements of federal and other funding agencies.

Most of these and other published authorship guidelines appear to be based on those disseminated in 1985 by the International Committee of Medical Journal Editors (ICMJE). The ICMJE established three criteria for authorship in biomedical research. “Authors” must take part in all of the following: significant contribution to all aspects of the study design, or data acquisition, analysis, and interpretation; initial draft preparation and/or critical editing and review of the manuscript; and approval of the final version before publication. The ICMJE guidelines also addressed the issue of acknowledging contributions that do not rise to the level of authorship.

Consistent with emerging efforts to prevent authorship conflicts and establish responsibility during scientific publication, many journals have been adding the new requirement of detailing each author’s contribution ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies